122 related articles for article (PubMed ID: 38088510)
1. METTL3-mediated m
Zhou YF; Li JT; Zheng QL; Ren KL; Yi CC
Kaohsiung J Med Sci; 2024 Feb; 40(2):150-160. PubMed ID: 38088510
[TBL] [Abstract][Full Text] [Related]
2. TRAF5 promotes the occurrence and development of colon cancer via the activation of PI3K/AKT/NF-κB signaling pathways.
Sun G; Zheng C; Deng Z; Huang C; Huang J
J Biol Regul Homeost Agents; 2020; 34(4):1257-1268. PubMed ID: 32911926
[TBL] [Abstract][Full Text] [Related]
3. METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma.
Shi K; Sa R; Dou L; Wu Y; Dong Z; Fu X; Yu H
Clin Epigenetics; 2023 Sep; 15(1):153. PubMed ID: 37742030
[TBL] [Abstract][Full Text] [Related]
4. NSUN2 promotes lung adenocarcinoma progression through stabilizing PIK3R2 mRNA in an m
Du X; Cheng C; Yang Y; Fan B; Wang P; Xia H; Ni X; Liu Q; Lu L; Wei L
Mol Carcinog; 2024 May; 63(5):962-976. PubMed ID: 38411298
[TBL] [Abstract][Full Text] [Related]
5. METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation.
Lin C; Li T; Wang Y; Lai S; Huang Y; Guo Z; Zhang X; Weng S
Cell Death Dis; 2023 Mar; 14(3):221. PubMed ID: 36977668
[TBL] [Abstract][Full Text] [Related]
6. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
7. Methyltransferase-like 3 promotes the progression of lung cancer via activating PI3K/AKT/mTOR pathway.
Cheng FW; Peng LM; Luo D
Clin Exp Pharmacol Physiol; 2022 Jul; 49(7):748-758. PubMed ID: 35434840
[TBL] [Abstract][Full Text] [Related]
8. FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K/AKT/NF-κB pathway.
Zhang J; Wang J; Yue K; Li P; Shen W; Qiao X; Wang Y; Wu X
BMC Pulm Med; 2023 Jan; 23(1):32. PubMed ID: 36690987
[TBL] [Abstract][Full Text] [Related]
9. METTL3-mediated m
Wu Y; Chang N; Zhang Y; Zhang X; Xu L; Che Y; Qiao T; Wu B; Zhou Y; Jiang J; Xiong J; Zhang J; Zhang J
J Exp Clin Cancer Res; 2021 Mar; 40(1):90. PubMed ID: 33676554
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA (let-7b-5p)-targeted DARS2 regulates lung adenocarcinoma growth by PI3K/AKT signaling pathway.
Xu Y; Chen X
Oncol Res; 2024; 32(3):517-528. PubMed ID: 38361754
[TBL] [Abstract][Full Text] [Related]
11. m
Ruan P; Wang S; Yang C; Huang X; Sun P; Tan A
Cell Biol Toxicol; 2023 Aug; 39(4):1611-1626. PubMed ID: 35971034
[TBL] [Abstract][Full Text] [Related]
12. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
[TBL] [Abstract][Full Text] [Related]
13. METTL3 regulatory TROAP can regulate the progression of non-small cell lung cancer through PI3K/AKT and EMT signaling pathway.
Xu M; Yu J; Liu X; Jia W; Duan Y; Ma D; Ma J; Lei W; Tai W
Med Oncol; 2023 Aug; 40(9):274. PubMed ID: 37608033
[TBL] [Abstract][Full Text] [Related]
14. RNA methyltransferase METTL3 induces intrinsic resistance to gefitinib by combining with MET to regulate PI3K/AKT pathway in lung adenocarcinoma.
Gao F; Wang Q; Zhang C; Zhang C; Qu T; Zhang J; Wei J; Guo R
J Cell Mol Med; 2021 Mar; 25(5):2418-2425. PubMed ID: 33491264
[TBL] [Abstract][Full Text] [Related]
15. [Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of
m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of
Lung Cancer].
Zhang Y; Wang Y; Liu M
Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):919-933. PubMed ID: 38163978
[TBL] [Abstract][Full Text] [Related]
16. IL-18 serves as a main effector of CAF-derived METTL3 against immunosuppression of NSCLC via driving NF-κB pathway.
Xu L; Li K; Li J; Xu F; Liang S; Kong Y; Chen B
Epigenetics; 2023 Dec; 18(1):2265625. PubMed ID: 37871286
[No Abstract] [Full Text] [Related]
17. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.
Bi X; Lv X; Liu D; Guo H; Yao G; Wang L; Liang X; Yang Y
Cancer Gene Ther; 2021 Apr; 28(3-4):335-349. PubMed ID: 32939058
[TBL] [Abstract][Full Text] [Related]
18. The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of
Ni XF; Xie QQ; Zhao JM; Xu YJ; Ji M; Hu WW; Wu J; Wu CP
Aging (Albany NY); 2021 Jan; 13(3):4357-4369. PubMed ID: 33495421
[TBL] [Abstract][Full Text] [Related]
19. METTL3 Modulates Osteoclast Differentiation and Function by Controlling RNA Stability and Nuclear Export.
Li D; Cai L; Meng R; Feng Z; Xu Q
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121289
[TBL] [Abstract][Full Text] [Related]
20. m6A methylated EphA2 and VEGFA through IGF2BP2/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K/AKT and ERK1/2 signaling.
Liu X; He H; Zhang F; Hu X; Bi F; Li K; Yu H; Zhao Y; Teng X; Li J; Wang L; Zhang Y; Wu Q
Cell Death Dis; 2022 May; 13(5):483. PubMed ID: 35595748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
